Venrock partner Racquel Bracken speaks with Markus Renschler, President and CEO of Cyteir Therapeutics, to discuss the journey that led him to Cyteir, and the company’s path to going public. Renschler dives into an important lesson his parents instilled in him from a young age, “be comfortable with being uncomfortable,” and explains how this lesson has played an important role in his career journey. As a practicing hematologist oncologist, Renschler highlights the value of people skills and how developing those skills can positively influence leadership style, recruiting, and even fundraising. Renschler shares some of his highs and lows along the drug development process, provides advice for young clinicians entering the industry, and how his experience as a practicing physician influences the decisions he makes as a CEO.
Emily Drabant Conley, CEO of Federation Bio, joins Venrock partner Racquel Bracken to chat about lessons learned from her time at 23andMe and how Federation Bio is disrupting the microbiome space. Conley discusses key takeaways from her experience in handling moments of crisis, including the importance of transparency and staying consistent with your company’s mission. As a female CEO, Conley shares what traits of 23andMe’s Anne Wojcicki she tries to emulate and discusses how setting aggressive goals has helped her career. Conley also discusses the opportunities that come with working at a small company and reveals her passion for cooking, which she’s ramped up during the pandemic.
Want more? Here’s the latest on Running Through Walls.
Jessica Lessin, founder and editor-in-chief of The Information, joins her college roommate, Venrock’s Racquel Bracken, to discuss the evolution of journalism and how she created one of the most successful subscription news sites in Silicon Valley. Jessica shares her journey from the middle school newspaper all the way to the Wall Street Journal and breaking out on her own to start the Information. She also shares her views on journalism’s role in the #metoo movement.